Carrier-mediated transport and efflux mechanisms in Caco-2 cells

被引:74
作者
Hidalgo, IJ
Li, JB
机构
[1] Drug Metab. and Pharmacokin. (NW12), Rhône-Poulenc Rorer Ctrl. Res., Collegeville, PA 19426-0107
关键词
Caco-2; cells; carrier; carrier mediated transport; active transport; efflux; p-glycoprotein; intestinal secretion;
D O I
10.1016/S0169-409X(96)00414-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Intestinal absorptive cells express a number of carrier systems that are responsible for the absorption of vitamins, bile acids, amino acids, nucleosides and di/tripeptides. The potential exploitability of these transporters for enhancing oral drug absorption is recognized. However, the structural specificities and functionalities of these transporters need to be characterized in greater detail before their exploitation in drug delivery can be realized. The study of intestinal transporters has been difficult because of the fragility and limited viability of intestinal enterocytes. One model system that has been proven to be useful in this type of study is the human colon adenocarcinoma cell line, Caco-2. Caco-2 cells form monolayers of differentiated epithelial cells joined by intercellular tight junctions, which prevent the paracellular diffusion of solutes. Thus, this system provides a selective barrier for modeling structure transport relationships for both passive and carrier mediated transport. In addition, Caco-2 cells express apical efflux mechanism(s), which may play a role in restricting oral drug absorption. Some enzymes and transport systems are expressed to a lesser extent in Caco-2 cells compared to normal enterocytes. This difference may be due to the colonic origin of Caco-2 cells. Thus, it is important to establish that transport proteins expressed by these cells are biochemically and/or functionally similar to the native transporter found in the small intestine. This comparison is important to establish the utility of the Caco-2 cell model for studying intestinal carriers.
引用
收藏
页码:53 / 66
页数:14
相关论文
共 82 条
[1]   EVIDENCE FOR ACTIVE-TRANSPORT OF TRIPEPTIDES BY HAMSTER JEJUNUM INVITRO [J].
ADDISON, JM ;
BURSTON, D ;
PAYNE, JW ;
WILKINSON, S ;
MATTHEWS, DM .
CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1975, 49 (04) :305-312
[2]   DEMONSTRATION THAT CFTR IS A CHLORIDE CHANNEL BY ALTERATION OF ITS ANION SELECTIVITY [J].
ANDERSON, MP ;
GREGORY, RJ ;
THOMPSON, S ;
SOUZA, DW ;
PAUL, S ;
MULLIGAN, RC ;
SMITH, AE ;
WELSH, MJ .
SCIENCE, 1991, 253 (5016) :202-205
[3]   EPITHELIAL TRANSPORT OF DRUGS IN CELL-CULTURE .1. A MODEL FOR STUDYING THE PASSIVE DIFFUSION OF DRUGS OVER INTESTINAL ABSORPTIVE (CACO-2) CELLS [J].
ARTURSSON, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (06) :476-482
[4]   EPITHELIAL TRANSPORT OF DRUGS IN CELL-CULTURE .2. EFFECT OF EXTRACELLULAR CALCIUM-CONCENTRATION ON THE PARACELLULAR TRANSPORT OF DRUGS OF DIFFERENT LIPOPHILICITIES ACROSS MONOLAYERS OF INTESTINAL EPITHELIAL (CACO-2) CELLS [J].
ARTURSSON, P ;
MAGNUSSON, C .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (07) :595-600
[5]   UTILIZATION OF PEPTIDE CARRIER SYSTEM TO IMPROVE INTESTINAL-ABSORPTION - TARGETING PROLIDASE AS A PRODRUG-CONVERTING ENZYME [J].
BAI, JPF ;
HU, M ;
SUBRAMANIAN, P ;
MOSBERG, HI ;
AMIDON, GL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (02) :113-116
[6]   STRUCTURAL REQUIREMENTS FOR THE INTESTINAL MUCOSAL-CELL PEPTIDE TRANSPORTER - THE NEED FOR N-TERMINAL ALPHA-AMINO GROUP [J].
BAI, PF ;
SUBRAMANIAN, P ;
MOSBERG, HI ;
AMIDON, GL .
PHARMACEUTICAL RESEARCH, 1991, 8 (05) :593-599
[7]   SUBSTRATE-SPECIFICITY AND SOME PROPERTIES OF PHENOL SULFOTRANSFERASE FROM HUMAN INTESTINAL CACO-2 CELLS [J].
BARANCZYKKUZMA, A ;
GARREN, JA ;
HIDALGO, IJ ;
BORCHARDT, RT .
LIFE SCIENCES, 1991, 49 (16) :1197-1206
[8]   TAUROCHOLATE TRANSPORT BY HUMAN ILEAL BRUSH-BORDER MEMBRANE-VESICLES [J].
BARNARD, JA ;
GHISHAN, FK .
GASTROENTEROLOGY, 1987, 93 (05) :925-933
[9]  
BERGAN T, 1984, SCAND J INFECT DIS, P83
[10]  
BOULENC X, 1992, J PHARMACOL EXP THER, V263, P1471